STATEN ISLAND, N.Y. — A shortage of a medicine commonly used to treat breathing issues is expected to get worse after a major supplier to United States hospitals shut down last week, CNN is reporting.
Liquid albuterol has been in short supply since last summer, according to the American Society of Health-System Pharmacists. It has been on the U.S. Food and Drug Administration’s shortages list since October, the report said.
Patients with breathing problems such as asthma are particularly affected by such a shortage.
The only company to make certain albuterol products, Akorn Operating Company LLC, filed for Chapter 11 bankruptcy in May 2020, the report said.
Albuterol is used regularly in children’s hospitals which are now being forced to look for other alternatives.
“Members are either forced to compound it themselves to make the product or go to an outside third party source who is compounding the product,” said Paula Gurz, senior director of pharmacy contracting with Premier Inc., a major group purchasing company.
MORE TO READ ABOUT HEALTH:
These over-the-counter eye drops, linked to vision loss and infections, have been recalled
Dear Abby: I’m sober. She’s not. Should we give it another try?